GPCR (STOCKS)
Structure Therapeutics Inc. American Depositary Shares
$43.500000
+0.570000 (+1.33%)
Prev close: $42.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Raymond C. Stevens
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,062.02M
- Employees
- 183
- P/E (TTM)
- -16.00
- P/B (TTM)
- 2.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
14
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.35 | $-0.35 | +0.0043 | +1.21% |
|
Dec 2025 (Q4)
|
$-1.22 | $-0.47 | -0.7454 | -157.06% |
|
Sep 2025 (Q3)
|
$-1.11 | $-0.36 | -0.7516 | -209.71% |
|
Jun 2025 (Q2)
|
$-1.08 | $-0.28 | -0.7987 | -283.93% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $209.63M |
| Research and Development | $248.90M |
| Operating Income/Loss | -$209.63M |
| Income/Loss From Continuing Operations After Tax | -$170.34M |
| Income/Loss From Continuing Operations Before Tax | -$169.73M |
| Income Tax Expense/Benefit | $607.00K |
| Net Income/Loss | -$170.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$170.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$170.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.88 |
| Diluted Earnings Per Share | -$0.88 |
| Basic Average Shares | 569,636,000 |
| Diluted Average Shares | 222,871,000 |
| Assets | $1.51B |
| Current Assets | $1.49B |
| Cash | $1.46B |
| Other Current Assets | $32.10M |
| Noncurrent Assets | $17.53M |
| Fixed Assets | $6.37M |
| Other Non-current Assets | $11.16M |
| Liabilities | $61.03M |
| Current Liabilities | $56.98M |
| Accounts Payable | $7.82M |
| Wages | $6.37M |
| Other Current Liabilities | $42.79M |
| Noncurrent Liabilities | $4.05M |
| Equity | $1.45B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.45B |
| Liabilities And Equity | $1.51B |
| Net Cash Flow From Operating Activities | -$154.74M |
| Net Cash Flow From Operating Activities, Continuing | -$154.74M |
| Net Cash Flow From Investing Activities | -$441.18M |
| Net Cash Flow From Investing Activities, Continuing | -$441.18M |
| Net Cash Flow From Financing Activities | $759.97M |
| Net Cash Flow From Financing Activities, Continuing | $759.97M |
| Net Cash Flow | $164.05M |
| Net Cash Flow, Continuing | $164.05M |
| Comprehensive Income/Loss | -$172.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$173.35M |
| Other Comprehensive Income/Loss | -$68.27M |
| Other Comprehensive Income/Loss Attributable To Parent | -$3.01M |